The danger or severity of methemoglobinemia could be enhanced when Navitoclax is coupled with Benzocaine. This trial was sponsored by Abbott Laboratories and Genentech. M06-814 was the initial in human protocol submitted by Abbott with the Original IND for ABT-263. Despite the fact that Abbott collaborated with advisors (such as https://titusgqbks.webbuzzfeed.com/26585014/the-best-side-of-mouse